2024-03-20 06:00:28 ET
Summary
- DocGo stock receives a buy rating due to attractive upside potential and commendable execution demonstrated by management.
- Recent results show strong revenue growth and margin expansion, driven by steady contracts and growth in trip volumes and average price.
- Management's positive commentary, impressive pipeline, and plans for RFP submissions in FY24 indicate continued momentum and cross-sell success.
Overview
Read the full article on Seeking Alpha
For further details see:
DocGo: Upside Remains Attractive After Share Price Decline